Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.9K
The pathophysiology of pneumonia involves the following steps:
3.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Acute Pharyngitis01:30

Acute Pharyngitis

5.3K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Torque Teno Virus Dynamics in Plasma and BAL of COVID-19 ARDS Patients With and Without ECMO.

Journal of medical virology·2026
Same author

Variability and interpretability of benzylpenicillin inhibition zone edges in Staphylococcus aureus - a multi-center study in Austria.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Mapping the Protein Phosphatase 1 Interactome in Human Cytomegalovirus Infection.

Viruses·2025
Same author

Unveiling Inter- and Intra-Patient Sequence Variability with a Multi-Sample Coronavirus Target Enrichment Approach.

Viruses·2024
Same author

Cyanovirin-N Binding to <i>N</i>-Acetyl-d-glucosamine Requires Carbohydrate-Binding Sites on Two Different Protomers.

Biochemistry·2024
Same author

The Distinct Regulation of the Vitamin D and Aryl Hydrocarbon Receptors in COVID-19.

Nutrients·2024
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Meningococcal pneumonia.

Matthias Vossen1, Dieter Mitteregger2, Christoph Steininger1

  • 1Department of Medicine I, Div. of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.

Vaccine
|July 23, 2016
PubMed
Summary
This summary is machine-generated.

Neisseria meningitidis causes bacterial meningitis globally. Meningococcal pneumonia, a severe complication, is underdiagnosed and requires clinical awareness for timely diagnosis and treatment.

Keywords:
Invasive meningococcal diseaseNeisseria meningitidisPneumonia

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

9.2K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Related Experiment Videos

Last Updated: Mar 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

9.2K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Area of Science:

  • Infectious Diseases
  • Pulmonary Medicine
  • Microbiology

Background:

  • Neisseria meningitidis is a leading cause of bacterial meningitis worldwide, especially in children and young adults.
  • Meningococcal pneumonia is the second most common severe end-organ manifestation of invasive meningococcal disease, affecting 5-15% of patients.
  • Diagnosis of meningococcal pneumonia requires high clinical suspicion, leading to likely underreporting and underestimation of its incidence.

Purpose of the Study:

  • To review and synthesize available data on meningococcal pneumonia.
  • To present risk factors, pathogenesis, clinical manifestations, diagnostic approaches, treatment, and prognosis.
  • To highlight the importance of recognizing this underdiagnosed condition.

Main Methods:

  • Systematic review of 344 reported cases of meningococcal pneumonia.
  • Data collection from the Americas, Europe, Australia, and Asia.
  • Analysis of cases reported between 1906 and 2015.

Main Results:

  • The review analyzed a significant number of cases over a century.
  • Key aspects including risk factors, clinical presentation, and outcomes were examined.
  • The study underscores the diagnostic challenges and potential for underestimation.

Conclusions:

  • Meningococcal pneumonia is a significant, though often underrecognized, complication of invasive meningococcal disease.
  • Increased clinical awareness is crucial for accurate diagnosis and management.
  • Further research may be needed to fully understand its epidemiology and optimize treatment strategies.